Russia and Ukraine agree to major prisoner exchange, but fail to reach broader ceasefire deal
Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
Russia and Ukraine agree to major prisoner exchange, but fail to reach broader ceasefire deal
Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.